4//SEC Filing
Levy Howard 4
Accession 0001209191-18-059044
CIK 0001124105other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 5:56 PM ET
Size
8.7 KB
Accession
0001209191-18-059044
Insider Transaction Report
Form 4
Levy Howard
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2018-11-16$4.63/sh+173$801→ 7,733 total - Sale
Common Stock
2018-11-16$11.00/sh−173$1,903→ 7,560 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-11-16−173→ 87,267 totalExercise: $4.63Exp: 2027-07-11→ Common Stock (173 underlying)
Footnotes (2)
- [F1]Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on September 5, 2018.
- [F2]The Option vests monthly over a period of four years commencing June 15, 2017.
Documents
Issuer
CATALYST BIOSCIENCES, INC.
CIK 0001124105
Entity typeother
Related Parties
1- filerCIK 0001672333
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 5:56 PM ET
- Size
- 8.7 KB